Abstract
The discrepancy between chronological age and the apparent age of the brain based on neuroimaging data — the brain age delta — has emerged as a reliable marker of brain health. With an increasing wealth of data, approaches to tackle heterogeneity in data acquisition are vital. To this end, we compiled raw structural magnetic resonance images into one of the largest and most diverse datasets assembled (n=53542), and trained convolutional neural networks (CNNs) to predict age. We achieved state-of-the-art performance on unseen data from unknown scanners (n=2553), and showed that higher brain age delta is associated with diabetes, alcohol intake and smoking. Using transfer learning, the intermediate representations learned by our model complemented and partly outperformed brain age delta in predicting common brain disorders. Our work shows we can achieve generalizable and biologically plausible brain age predictions using CNNs trained on heterogeneous datasets, and transfer them to clinical use cases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by the UiO:LifeScience Convergence Environment (project: 4MENT), The Research Council of Norway (302854, 223273, 249795, 298646, 300767), the South-Eastern Norway Regional Health Authority (2014097, 2016083, 2018037, 2018076, 2019101), Stiftelsen Kristian Gerhard Jebsen, ERA-Net Cofund through the ERA PerMed project IMPLEMENT, and the European Research Council under the European Union's Horizon 2020 research and Innovation program (ERC StG, Grant 802998) and the Wellcome Trust grant (215698/Z/19/Z). T.W. gratefully acknowledges support from the European Unions Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 895011. A.F.M. gratefully acknowledges support from the European Research Council (ERC, grant number 10100118) and the Dutch Organisation for Scientific Research (016.156.415). Part of the computation was performed on the Norwegian high-performance computation resources, sigma2 (NN9767K/NS9769K). Funding for the various datasets used can be found in the supplementary information.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All data sets used in the present study have been obtained from previously published studies which have been approved by their respective institutional review board or relevant research ethics committee. A detailed overview of the data sources can be found in the supplementary information.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The raw data incorporated in this work were gathered from various resources. Material requests will need to be placed with individual principal investigators. A detailed overview of the independent datasets, and their origins, is provided in the supplementary information.
